Beijing Biocytogen in vivo efficacy testing platform comprises a number of core staff from well-known pharmaceutical companies at home and abroad, who have rich experiences in drug research and development. Integrating the service resources of other relevant departments (such as molecular biology, cell biology, animal production and breeding, etc.) and combining with the trend and technology of modern drug research and development, the platform relies on its own strong technical support and new model animals, establishes a variety of tumor animal models for different targets and forms a set of tumor drug efficacy testing technology with own characteristics.
In strict accordance with international standards, in vivo efficacy testing platform is able to carry out preclinical in vivo pharmacodynamics, pharmacokinetics, toxicology, biomarkers and other research experiments, which provides reliable data support for clinical trials of tumor antibody drugs.
Perkinelmer In vivo Imaging System Attune NxT Flow Cytometer 【Return list】